Stock data
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET) reported net income of -US$116.80M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$122.11M | -US$116.80M | — |
| 2024 | — | — | -US$127.61M | -US$117.12M | — |
| 2023 | — | — | -US$152.04M | -US$142.66M | — |
| 2022 | — | — | -US$72.55M | -US$69.79M | — |
| 2021 | — | — | -US$61.43M | -US$62.00M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$21.36M | — |
| 2026-03-31 | — | -US$20.24M | — |
| 2025-12-31 | — | -US$30.52M | — |
| 2025-09-30 | — | -US$26.86M | — |
| 2025-06-30 | — | -US$31.22M | — |
| 2025-03-31 | — | -US$28.21M | — |
| 2024-12-31 | — | -US$28.73M | — |
| 2024-09-30 | — | -US$30.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.